These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 17459771

  • 1. Assessment of efficacy of pharmacotherapy for ventricular tachycardia.
    Cooper MJ.
    Heart Lung Circ; 2007 Jun; 16(3):170-5. PubMed ID: 17459771
    [Abstract] [Full Text] [Related]

  • 2. Management of ventricular arrhythmias.
    Aronow WS.
    Compr Ther; 1988 Aug; 14(8):25-30. PubMed ID: 3048863
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Ventricular pro-arrhythmic effects of anti-arrhythmia drugs].
    Jaillon P, Simon T.
    Therapie; 1992 Aug; 47(3):187-92. PubMed ID: 1295119
    [Abstract] [Full Text] [Related]

  • 6. Surgery and ablative therapy for ventricular tachycardia.
    Ross DL.
    Heart Lung Circ; 2007 Jun; 16(3):214-21. PubMed ID: 17446128
    [Abstract] [Full Text] [Related]

  • 7. [Acute treatment of stable hemodynamically tolerable ventricular tachycardia].
    Haverkamp W, Rolf S, Stockburger M, Dietz R.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):207-12. PubMed ID: 15832239
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [How to develop an anti-arrhythmia agent in 1990. The cardiologist's viewpoint].
    Touboul P.
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():57-62. PubMed ID: 1726997
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A, Pieragnoli P, Ricciardi G, Giaccardi M, Padeletti L, Michelucci A.
    Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
    [Abstract] [Full Text] [Related]

  • 17. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S, Duker G, Carlsson L.
    Prog Biophys Mol Biol; 2008 Jun; 98(2-3):328-39. PubMed ID: 19038282
    [Abstract] [Full Text] [Related]

  • 18. [Out-of- or in-hospital occurrences of malignant ventricular tachyarrhythmias: the prognostic significance in the population enrolled in the AVID study. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E.
    Ital Heart J Suppl; 2000 Apr; 1(4):579-80. PubMed ID: 10832150
    [No Abstract] [Full Text] [Related]

  • 19. [Pertinence of animal and human models in the evaluation of ventricular anti-arrhythmia agents].
    Funck-Brentano C, Le Heuzey JY.
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():15-20. PubMed ID: 1726994
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.